BMO Capital Initiates Coverage On Conmed with Market Perform Rating, Announces Price Target of $36
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsInitiationPrice Target
BMO Capital initiates coverage on Conmed (NYSE:CNMD) with a Market Perform rating and announces Price Target of $36.
BMO Capital initiates coverage on Conmed (NYSE:CNMD) with a Market Perform rating and announces Price Target of $36.